| Lactose (India) Ltd | 98.4 Cr. | 78.2 | 137/76.0 | 20.4 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.17/1.57 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 2,744 Cr. | 252 | 479/222 | 57.4 | 24.3 | 0.27 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 25.8 Cr. | 33.1 | 68.4/32.5 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 109 Cr. | 74.5 | 75.5/17.0 | 437 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 86.8 Cr. | 85.7 | 115/69.7 | 24.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 61,252 Cr. | 2,170 | 2,298/1,336 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 195 Cr. | 8.01 | 17.2/7.87 | 11.1 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.35 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 927 Cr. | 1,694 | 1,999/635 | 27.2 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 89.4 Cr. | 17.9 | 29.8/16.0 | 25.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,007 Cr. | 342 | 399/241 | 11.4 | 133 | 0.73 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.09 Cr. | 14.7 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 6.27 Cr. | 2.52 | 6.11/2.36 | 3.56 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 226 Cr. | 233 | 536/219 | 38.7 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,388 Cr. | 1,238 | 1,511/944 | 46.3 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 23.7 Cr. | 9.03 | 26.3/7.45 | 11.6 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 5.38 Cr. | 5.33 | 12.5/5.30 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 132 Cr. | 371 | 785/360 | 9.26 | 596 | 0.40 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 70.2 Cr. | 70.2 | 92.5/29.0 | 133 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 10,662 Cr. | 1,018 | 2,150/990 | 33.6 | 174 | 1.05 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 5.61 Cr. | 44.5 | 87.9/36.1 | 11.4 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.7 Cr. | 111 | 153/75.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 25.7 Cr. | 47.0 | 144/12.2 | 12.5 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 23.0 Cr. | 30.5 | 61.5/30.0 | 37.1 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.26 Cr. | 20.8 | 24.4/15.7 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 5,686 Cr. | 327 | 1,028/325 | 19.4 | 72.4 | 0.37 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 61.5 Cr. | 14.2 | 28.8/14.1 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 9.78 Cr. | 19.3 | 30.0/15.9 | 978 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 82,746 Cr. | 2,006 | 2,727/1,910 | 46.8 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 203 Cr. | 353 | 524/241 | 19.5 | 123 | 1.28 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 68.5 Cr. | 47.7 | 51.9/26.7 | 92.6 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 75,786 Cr. | 1,304 | 1,331/994 | 21.5 | 603 | 0.31 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 165 Cr. | 265 | 317/159 | 56.0 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 672 Cr. | 67.0 | 115/66.7 | 16.1 | 32.6 | 2.24 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 24.1 Cr. | 18.4 | 39.7/17.6 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 20,953 Cr. | 2,559 | 2,580/930 | 73.0 | 173 | 0.06 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.90 Cr. | 0.59 | 0.97/0.50 | 55.7 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 186 Cr. | 24.3 | 42.0/23.1 | 10.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.31 Cr. | 12.5 | 19.1/7.60 | 244 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 124 Cr. | 5.27 | 6.80/3.00 | 289 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 55,026 Cr. | 25,915 | 37,000/25,350 | 36.1 | 1,888 | 1.83 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,364 Cr. | 592 | 972/557 | 24.8 | 226 | 0.84 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 144 Cr. | 50.8 | 100/33.7 | 42.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 3,627 Cr. | 1,065 | 1,740/752 | | 93.5 | 0.09 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 19,111 Cr. | 1,176 | 1,870/1,087 | 176 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 763 Cr. | 222 | 330/162 | 17.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 43.9 Cr. | 5.28 | 29.4/5.26 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,088 Cr. | 820 | 950/286 | 14.3 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,068 Cr. | 293 | 712/278 | 19.7 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,054 Cr. | 740 | 1,402/735 | 15.1 | 768 | 1.35 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,42,804 Cr. | 4,220 | 4,483/3,101 | 61.9 | 250 | 0.76 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 609 Cr. | 66.1 | 179/65.0 | | 41.3 | 0.76 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 967 Cr. | 10.3 | 23.5/10.2 | 14.0 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,553 Cr. | 301 | 1,250/267 | 38.4 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,478 Cr. | 132 | 303/114 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,21,130 Cr. | 1,757 | 1,851/1,547 | 34.7 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 1,879 Cr. | 426 | 734/422 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,507 Cr. | 375 | 434/175 | 40.2 | 81.2 | 0.11 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,817 Cr. | 349 | 502/260 | 38.5 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 7,390 Cr. | 3,210 | 6,718/3,151 | 21.3 | 326 | 2.34 % | 57.5 % | 43.0 % | 10.0 |
| RPG Life Sciences Ltd | 3,088 Cr. | 1,858 | 2,725/1,731 | 29.4 | 335 | 1.08 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 7,990 Cr. | 4,799 | 6,739/4,725 | 27.2 | 373 | 2.60 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 97.6 Cr. | 27.7 | 73.4/27.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,613 Cr. | 4,720 | 5,993/3,701 | 28.4 | 841 | 0.74 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 96.7 Cr. | 78.6 | 122/78.0 | 6.95 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 1,815 Cr. | 296 | 582/292 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 2,441 Cr. | 482 | 899/471 | 94.0 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 15,424 Cr. | 12,027 | 19,748/10,060 | 86.1 | 1,263 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 180 Cr. | 9.30 | 28.3/9.30 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 17,456 Cr. | 974 | 1,060/660 | 11.2 | 483 | 0.62 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,847 Cr. | 33.7 | 70.5/33.0 | 24.2 | 21.8 | 0.59 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,122 Cr. | 157 | 271/155 | 19.8 | 59.3 | 0.51 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 43.0 Cr. | 27.2 | 95.0/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 160 Cr. | 45.0 | 129/44.1 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,05,780 Cr. | 2,314 | 2,378/1,774 | 21.3 | 430 | 0.52 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,128 Cr. | 565 | 679/440 | 12.8 | 357 | 0.32 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,565 Cr. | 993 | 1,141/517 | 66.9 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,355 Cr. | 1,306 | 1,740/666 | 23.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 86.2 Cr. | 39.8 | 114/38.3 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 521 Cr. | 108 | 215/107 | 31.5 | 104 | 2.78 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 439 Cr. | 124 | 250/117 | 16.9 | 75.9 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,006 Cr. | 816 | 1,250/784 | 28.2 | 414 | 0.61 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 33,129 Cr. | 2,064 | 2,195/1,303 | 44.0 | 243 | 0.75 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,241 Cr. | 184 | 302/155 | 29.1 | 37.9 | 1.36 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 40,683 Cr. | 1,601 | 1,624/1,168 | 38.5 | 293 | 0.25 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,137 Cr. | 72.8 | 127/57.5 | 17.2 | 59.7 | 1.37 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,073 Cr. | 131 | 152/67.2 | 22.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,512 Cr. | 164 | 350/162 | | 106 | 0.12 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 1,813 Cr. | 147 | 457/146 | 72.5 | 96.9 | 0.95 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,070 Cr. | 1,259 | 2,350/1,239 | 26.1 | 397 | 0.56 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,735 Cr. | 274 | 409/268 | 54.1 | 62.7 | 0.04 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 15,082 Cr. | 620 | 640/412 | 27.8 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 60,157 Cr. | 2,132 | 2,298/1,336 | 22.2 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 38,681 Cr. | 2,283 | 3,516/2,218 | 38.5 | 101 | 1.84 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,869 Cr. | 1,696 | 2,131/1,200 | 23.5 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,217 Cr. | 321 | 528/313 | 22.5 | 149 | 1.56 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 17,956 Cr. | 1,297 | 1,910/1,097 | 40.5 | 227 | 0.57 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,721 Cr. | 1,255 | 1,380/1,020 | 18.8 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,033 Cr. | 130 | 322/128 | 15.4 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 98,861 Cr. | 1,224 | 1,673/1,215 | 20.8 | 408 | 1.06 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 11,447 Cr. | 1,505 | 2,397/1,500 | 18.6 | 416 | 0.40 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 109 Cr. | 37.1 | 166/36.3 | 5.05 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,269 Cr. | 216 | 244/105 | 20.5 | 107 | 0.23 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 41.5 Cr. | 25.8 | 57.2/25.6 | 15.0 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 58,499 Cr. | 361 | 425/295 | 71.2 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,206 Cr. | 1,189 | 2,000/990 | 28.0 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 96.2 Cr. | 60.4 | 129/59.7 | 11.8 | 49.2 | 1.99 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 260 Cr. | 109 | 205/70.6 | 22.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 19,377 Cr. | 7,766 | 10,691/6,502 | 93.1 | 320 | 0.41 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,423 Cr. | 494 | 791/486 | 24.6 | 118 | 0.93 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 97.9 Cr. | 46.5 | 120/46.0 | 8.29 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 63,369 Cr. | 5,299 | 5,934/4,612 | 26.4 | 1,116 | 0.85 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 13,036 Cr. | 663 | 1,108/635 | 19.6 | 271 | 1.66 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 336 Cr. | 587 | 959/580 | 35.0 | 690 | 0.85 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 34,877 Cr. | 2,805 | 3,228/2,022 | 34.4 | 345 | 1.00 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 2,863 Cr. | 255 | 367/252 | 19.9 | 133 | 2.04 % | 13.1 % | 9.54 % | 2.00 |
| Industry Average | 20,995.08 Cr | 1,036.83 | | 52.45 | 201.20 | 0.41% | 16.35% | 15.16% | 6.10 |